Meta Analysis of IL1B Promoter Region Polymorphism and Cancer Risk
CHEN Li-ping,GU Ling,NIE Zhen-lin,XU Ye-qiong,LI Rui,GAO Tian-yi,SONG Guo-qi,WANG Shu-kui
DOI: https://doi.org/10.3969/j.issn.1674-1633.2012.11.005
2012-01-01
Abstract:IL1B(Interleukin 1beta) is a pro-in?ammatory cytokine against infection,playing an important role in the growth of cancers.The-31T/C polymorphism sites of the IL1B gene promoter region have participated in cancer occurrence through its in?uence on IL1B transcription.However,informed reasearch has different results.To clarify the association,a meta analysis has been performed for 11125 cases and 14415 controls from 47 published case–control studies.Odds ratio(OR) and 95% con?dence interval(CI) could assess connection degree of polymorphic site and cancer risk.The polymorphic site has not connected with all cancers in all comparisons.Through strati?ed analyses,the individual carrying C allele has lower risk than non-carrier(CC vs TT: OR = 0.87,95%CI: 0.77~0.98,Pheterogeneity= 0.103;TC vs TT: OR = 0.77,95%CI: 0.62~0.95,Pheterogeneity = 0.734;TC+CC vs TT: OR = 0.74,95%CI: 0.61~0.91,Pheterogeneity = 0.472).Similarly,the T/T genotype individual is easier to get gastric cancer compared with the C/C genotype(OR = 0.87,95%CI: 0.77~0.98,Pheterogeneity = 0.103).Using the recessive model,the risk of gastric cancer observably reduces(OR = 0.88,95%CI: 0.80~0.97,Pheterogeneity = 0.158).In european population(OR = 0.84,95%CI: 0.73~0.97,Pheterogeneity = 0.070) and infection-matched studies(OR = 0.75,95%CI: 0.60~0.94,Pheterogeneity = 0.220),the risk also notablely decreases;however,an increasing risk is found from breast cancer(OR=1.34,95%CI: 1.18~1.61,Pheterogeneity =0.116).Although some modest biases could not be eliminated,this meta-analysis shows that the IL1B-31C allele is a protective factor for cancer,particularly the infections.